Lv1
40 积分 2026-01-06 加入
Nanoparticle-Based Drug Delivery for Chronic Obstructive Pulmonary Disorder and Asthma
26天前
已完结
三种方法气管灌注博来霉素诱导小鼠肺纤维化的比较
1个月前
已完结
Dual PDE 3/4 inhibition: a novel approach to airway disease?
1个月前
已关闭
ENSIFENTRINE, A DUAL PDE 3 AND 4 INHIBITOR, PROVIDES EFFECTIVE BRONCHODILATION IN PATIENTS WITH COPD WHEN ADMINISTERED TWICE DAILY OVER 7 DAYS VIA PMDI
1个月前
已关闭
Antifibrotic and Anti-inflammatory Activity of the Tyrosine Kinase Inhibitor Nintedanib in Experimental Models of Lung Fibrosis
2个月前
已完结
Ensifentrine: First Approval
2个月前
已完结
Kinases as Novel Therapeutic Targets in Asthma and Chronic Obstructive Pulmonary Disease
3个月前
已完结
Inhaled Phosphodiesterase Inhibitors for the Treatment of Chronic Obstructive Pulmonary Disease
3个月前
已完结
Effects of the DPP-1 inhibitor HSK31858 in adults with bronchiectasis in China (SAVE-BE): a phase 2, multicentre, double-blind, randomised, placebo-controlled trial
4个月前
已完结
Effects of the DPP-1 inhibitor HSK31858 in adults with bronchiectasis in China (SAVE-BE): a phase 2, multicentre, double-blind, randomised, placebo-controlled trial
5个月前
已完结
皖公网安备34019202002308
